Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Shares Issued (2020 - 2025)

Zai Lab (ZLAB) has disclosed Shares Issued for 6 consecutive years, with $249000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 99.88% to $249000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Dec 2025, down 93.71% year-over-year, with the annual reading at $13.7 million for FY2025, 93.71% down from the prior year.
  • Shares Issued hit $249000.0 in Q4 2025 for Zai Lab, down from $2.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $818.2 million in Q2 2021 to a low of -$811.5 million in Q4 2021.
  • Historically, Shares Issued has averaged $13.7 million across 5 years, with a median of $861500.0 in 2021.
  • Biggest five-year swings in Shares Issued: crashed 171.58% in 2021 and later soared 45863.62% in 2024.
  • Year by year, Shares Issued stood at -$811.5 million in 2021, then surged by 100.03% to $230000.0 in 2022, then skyrocketed by 104.35% to $470000.0 in 2023, then skyrocketed by 45863.62% to $216.0 million in 2024, then plummeted by 99.88% to $249000.0 in 2025.
  • Business Quant data shows Shares Issued for ZLAB at $249000.0 in Q4 2025, $2.0 million in Q3 2025, and $8.4 million in Q2 2025.